SPARC-derived tumor rejection antigenic peptides and medicaments comprising the same

Details for Australian Patent Application No. 2007259667 (hide)

International Classifications

Event Publications

29 January 2009 Amendment Made

The nature of the amendment is: Amend the invention title to read SPARC-derived tumor rejection antigenic peptides and medicaments comprising the same

29 January 2009 PCT application entered the National Phase

PCT publication WO2007/145318 Priority application(s): WO2007/145318

27 January 2011 Assignment before Grant

ONCOTHERAPY SCIENCE, INC.; KUMAMOTO UNIVERSITY The application has been assigned to ONCOTHERAPY SCIENCE, INC.

14 June 2012 Application Accepted

Published as AU-B-2007259667

11 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.